HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide].

Abstract
We report a case of retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide. A 59-year-old man received tumorectomy and right nephrectomy for the retroperitoneal liposarcoma. Twenty-two months after the operation, the liver metastasis was resected incompletely. Three months later, right pleural, retroperitoneal and peritoneal metastases appeared. With 6 cycles of high-dose ifosfamide therapy these tumors were reduced partially. Ten cycles of this chemotherapy were administered. These tumors showed regrowth at 14 months after administration of high dose ifosfamide. The combination chemotherapy of ifosfamide and doxorubicine or etoposide was not effective after regrowth of the tumors.
AuthorsK Fujinami, K Kondoh, I Kondoh, T Miura, K Kushida
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 45 Issue 7 Pg. 463-6 (Jul 1999) ISSN: 0018-1994 [Print] Japan
PMID10466061 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Ifosfamide
Topics
  • Antineoplastic Agents, Alkylating (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Humans
  • Ifosfamide (administration & dosage)
  • Liposarcoma (drug therapy, secondary, surgery)
  • Liver Neoplasms (secondary)
  • Male
  • Middle Aged
  • Peritoneal Neoplasms (secondary)
  • Pleural Neoplasms (secondary)
  • Retroperitoneal Neoplasms (drug therapy, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: